Accelerating Japan to Global, and Global to Japan
AskAt’s research and development and management team have many decades of experience. This team formed the core of Pfizer’s drug discovery research in Japan for many years. We launched RaQualia, Pfizer’s first organic spin-off venture, and subsequently AskAt, as new bio-pharmaceutical development companies. AskAt manages our own multi-compound portfolio, and in addition we are offering advisory services to connect global investors and Japan-based founders with new growth opportunities.